Parameters of high-density lipoproteins in patients with arterial hypertension in combination with other components of metabolic syndrome

被引:0
|
作者
I. N. Ozerova
N. V. Perova
N. V. Shchel’tsyna
M. N. Mamedov
机构
[1] Federal Agency on Health Care and Social Development,Department of Metabolic Disorders, State Research Center for Preventive Medicine
来源
Bulletin of Experimental Biology and Medicine | 2007年 / 143卷
关键词
high-density lipoproteins; phospholipids; apoprotein A1; arterial hypertension; metabolic syndrome;
D O I
暂无
中图分类号
学科分类号
摘要
Parameters of HDL (concentrations of cholesterol, apoprotein A1, and phospholipids and phospholipid composition) determining their functional properties were studied in patients with arterial hypertension in combination with other components of metabolic syndrome (abdominal obesity, hyperlipidemia, and impaired glucose tolerance). Patients with isolated arterial hypertension did not differ from the control group by the concentration of apoprotein A1 and HDL cholesterol, but had lower content of HDL phospholipids and changed phospholipid composition: lower ratio of phosphatidylcholine and higher relative contents of lysophosphatidylcholine, sphingomyelin, and phosphatidylethanolamine. Parameters of HDL in patients with arterial hypertension associated with other components of metabolic syndrome did not differ from those in patients with isolated arterial hypertension. The observed changes in HDL in patients with arterial hypertension alone or in combination with other components of metabolic syndrome can impair functional capacity of HDL in reverse cholesterol transport, which increases the risk of atherosclerosis.
引用
收藏
页码:320 / 322
页数:2
相关论文
共 50 条
  • [31] Treatment of patients with severe deficency of high-density lipoproteins (HDL)
    Alrasadi, K. H.
    Awan, Z.
    Rondeau, C.
    Marcil, M.
    Genest, J.
    CANADIAN JOURNAL OF CARDIOLOGY, 2007, 23 : 286C - 286C
  • [32] IMPAIRMENTS IN METABOLISM OF HIGH-DENSITY LIPOPROTEINS IN PATIENTS WITH ISCHEMIC INSULT
    AITBAEV, KA
    VOPROSY MEDITSINSKOI KHIMII, 1982, 28 (06): : 48 - 50
  • [33] Insulin Resistance in Patients with Arterial Hypertension and Metabolic Syndrome
    Shlyakhto, Evgeny
    Chubenko, Ekaterina
    Belyaeva, Olga
    Berkovich, Olga
    Karonova, Tatiana
    Baranova, Elena
    HYPERTENSION, 2011, 58 (05) : E115 - E116
  • [34] Heart pathology in patients with arterial hypertension and metabolic syndrome
    Sharipova, G. Kh.
    Ataullakhanova, D. M.
    Mychka, V. B.
    Saidova, M. A.
    Chazova, I. E. A. L.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2008, 7 (08): : 20 - 26
  • [35] PECULIARITIES OF TREATMENT OF ARTERIAL HYPERTENSION IN PATIENTS WITH METABOLIC SYNDROME
    Gaspar, Ludovit
    Mesarosova, Dasa
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL 1) : E270 - E270
  • [36] Acarbose in patients with mild arterial hypertension and metabolic syndrome
    Bogieva, R
    Mychka, V
    Masenko, V
    Chazova, I
    JOURNAL OF HYPERTENSION, 2004, 22 : S91 - S92
  • [37] Metabolic syndrome diagnosis in patients with arterial hypertension and obesity
    Erivantseva, T. N.
    Olimpieva, S. P.
    Chazova, I. E.
    Mychka, V. B.
    Kilikovsky, V. V.
    TERAPEVTICHESKII ARKHIV, 2006, 78 (04) : 9 - 15
  • [38] Structural remodeling of high-density lipoproteins in patients with diabetes mellitus
    Baveghems, Clive
    Jayaraman, Shobini
    Gursky, Olga
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [39] CHARACTERIZATION OF HIGH-DENSITY LIPOPROTEINS IN PATIENTS HETEROZYGOUS FOR TANGIER DISEASE
    ASSMANN, G
    SIMANTKE, O
    SCHAEFER, HE
    SMOOTZ, E
    JOURNAL OF CLINICAL INVESTIGATION, 1977, 60 (05): : 1025 - 1035
  • [40] Bisoprolol and metformin in patients with arterial hypertension and metabolic syndrome
    Nevzorova, V. A.
    Zakcharchuk, N. V.
    Nastradin, O. V.
    Pomogalova, O. G.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2007, 3 (05) : 54 - 57